Which closed-end funds own Sarepta Therapeutics Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $39.5M. Security type: common equity. Country: United States. CUSIP 803607100 · ISIN US8036071004 · ticker SRPT.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 1.57% | $16.6M | 921,334 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 1.12% | $7.7M | 428,795 sh | $690M | 3.5% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 1.11% | $15.2M | 844,819 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| JCE Nuveen Core Equity Alpha Fund | U.S. Equity | 0.01% | $26.2K | 1,460 sh | $302M | 5.9% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Sarepta Therapeutics Inc | debt security | 4 |
Issuer-level search for “SRPT” → · Compare two funds’ portfolios →